Leptomeningeal metastatic hormone receptor positive, HER2 and PD-L1 negative, breast cancer responds after pembrolizumab added to abemaciclib: A case study :: Library Catalog

library@stipram.ac.id (0274) 485 650

Pengumuman Berita Terbaru PMB

Leptomeningeal metastatic hormone receptor positive, HER2 and PD-L1 negative, breast cancer responds after pembrolizumab added to abemaciclib: A case study

oleh: Melissa Mahoney, Frankie Ann Holmes, Benjamin Cho

Format:	Article
Diterbitkan:	Elsevier 2020-12-01

Deskripsi

Subjek

Metastatic breast cancer; Leptomeningeal disease; Pembrolizumab; Abemaciclib; PDL-1